Monday, May 29, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Funding News

UK Biomanufacturing Fund to Bolster Supply Chain Resilience and Pandemic Preparedness

by Global Biodefense Staff
May 26, 2023
Vials of finished vaccines

Photo credit: Wesley Farnsworth

Fund supports domestic commercial-scale vaccines and biotherapeutics manufacturing projects to improve health resilience for future pandemics.

The UK Biomanufacturing Fund (BMF) will provide up to £38 million in capital grants to incentivize investment in the manufacture of vaccines and biotherapeutics.

The BMF follows on from the £60 million Life Sciences Innovative Manufacturing Fund and the £20 million Medicines and Diagnostics Manufacturing Transformation Fund. The BMF will increase health resilience in the UK for future pandemics through increased domestic capacity, and more flexibility to re-deploy resources in an emergency.

Applications are currently being accepted for investment from companies manufacturing active pharmaceutical ingredient, component materials (starting materials, delivery systems, adjuvants), or conducting fill/finish of vaccines and biotherapeutics

Funding for this effort is focused on manufacture of human medicines, and will not be open to veterinary medicines or consumables (such as vials or syringes). Qualifying projects must be a manufacturing project (for commercial sale or clinical trials); be located in the UK; and have a total investment value of more than £12 million.

Applications for Phase 1 are due 30 June 2023.

Tags: BiomanufacturingEditor PickManufacturing CapacityOpportunitiesSupply Chain

Related Posts

Aptitude Awarded Up to $54M BARDA Funding for At-Home Diagnostics
Industry News

Aptitude Awarded Up to $54M BARDA Funding for At-Home Diagnostics

April 20, 2023
Medical Countermeasures

Scientists Design Molecule to Slow SARS-Cov-2 Infection

March 29, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
Load More

Latest News

Vials of finished vaccines

UK Biomanufacturing Fund to Bolster Supply Chain Resilience and Pandemic Preparedness

May 26, 2023
Dr. Sen Pei Discusses Challenges in Forecasting Antimicrobial Resistance

Dr. Sen Pei Discusses Challenges in Forecasting Antimicrobial Resistance

April 26, 2023
Biodefense Headlines – 25 April 2023

Biodefense Headlines – 25 April 2023

April 25, 2023
Aptitude Awarded Up to $54M BARDA Funding for At-Home Diagnostics

Aptitude Awarded Up to $54M BARDA Funding for At-Home Diagnostics

April 20, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2023 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2023 Stemar Media Group LLC

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are okay with it.OkPrivacy policy